肝动脉灌注泵:术中决策与HAI特异性并发症管理的外科工具包
本文综述肝动脉灌注(HAI)泵植入的操作要点,聚焦术中常见技术陷阱及解决方案,并描述术后并发症的围术期识别与管理。HAI特异性术后并发症发生率为22%至28%,多数患者通过早期识别和积极干预可得到挽救,以继续安全有效地实施HAI治疗。
要点
- HAI泵植入需关注术中技术陷阱与异常肝灌注,多数有对应解决方案。
- HAI特异性并发症发生率为22%至28%,涉及泵袋、导管、血管及胆道。
- 早期识别和积极干预可使多数并发症患者得到挽救并继续HAI治疗。
核心结论
- HAI工具包为HAI团队提供常见围术期障碍和并发症的管理参考,克服这些挑战对安全有效植入泵和实施HAI治疗至关重要。
研究设计与样本
- 本综述描述HAI泵植入的实施方法,重点讨论常见技术陷阱及相关解决方案,并描述常见术后并发症的围术期识别与管理。
主要发现
- HAI治疗最常通过手术植入皮下泵并将导管置入肝动脉系统,使泵化疗药物直接 inline 流向肝脏。
- 术中挑战和异常肝灌注可因解剖变异、血管疾病、技术或患者因素而出现,但多数病例存在预防或克服技术陷阱的解决方案。
- HAI特异性术后并发症发生率为22%至28%,包括泵袋并发症8%至18%、导管并发症10%至26%、血管并发症5%至10%、胆道并发症2%至8%。
- 多数患者可通过早期识别和积极干预从这些并发症中得到挽救,以继续安全有效地实施HAI治疗。
关键数值与推荐
- HAI特异性术后并发症总发生率为22%至28%。
- 泵袋并发症发生率为8%至18%。
- 导管并发症发生率为10%至26%。
- 血管并发症发生率为5%至10%。
- 胆道并发症发生率为2%至8%。
临床怎么用
- HAI团队可参考本工具包管理术中常见技术陷阱和术后HAI特异性并发症。
- 对HAI术后患者应早期识别泵袋、导管、血管及胆道并发症并积极干预,以继续安全有效的HAI治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatic artery infusion (HAI) is a liver-directed therapy that delivers high-dose chemotherapy to the liver through the hepatic arterial system for colorectal liver metastases and intrahepatic cholangiocarcinoma. Utilization of HAI is rapidly expanding worldwide. OBJECTIVE AND METHODS: This review describes the conduct of HAI pump implantation, with focus on common technical pitfalls and their associated solutions. Perioperative identification and management of common postoperative complications is also described. RESULTS: HAI therapy is most commonly performed with the surgical implantation of a subcutaneous pump, and placement of its catheter into the hepatic arterial system for inline flow of pump chemotherapy directly to the liver. Intraoperative challenges and abnormal hepatic perfusion can arise due to aberrant anatomy, vascular disease, technical or patient factors. However, solutions to prevent or overcome technical pitfalls are present for the majority of cases. Postoperative HAI-specific complications arise in 22% to 28% of patients in the form of pump pocket (8%-18%), catheter (10%-26%), vascular (5%-10%), or biliary (2%-8%) complications. The majority of patients can be rescued from these complications with early identification and aggressive intervention to continue to deliver safe and effective HAI therapy. CONCLUSIONS: This HAI toolkit provides the HAI team a reference to manage commonly encountered HAI-specific perioperative obstacles and complications. Overcoming these challenges is critical to ensure safe and effective pump implantation and delivery of HAI therapy, and key to successful implementation of new programs and expansion of HAI to patients who may benefit from such a highly specialized treatment strategy.
引用
- Sharib JM, Creasy JM, Wildman-Tobriner B, et al. Hepatic Artery Infusion Pumps: A Surgical Toolkit for Intraoperative Decision-Making and Management of Hepatic Artery Infusion-Specific Complications. Ann Surg. 2022. PMID: 36346892. doi:10.1097/SLA.0000000000005434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。